BioAgenda

BioAgenda 2006 Summit Speakers and Moderators  Print This Page 

Back to Summit | Summit Program | Summit Issues |

 

Click on names for detailed bios

  • George H. Atkinson, PhD, Science and Technology Adviser to the Secretary of State; Professor of Chemistry and Optical Sciences, University of Arizona
  • Rashmi Barbhaiya, PhD, CEO and Co-Founder, Advinus Therapeutics; former President of R&D at Ranbaxy 
  • Seth Berkley, MD, President and CEO and Founder, International AIDS Vaccine Initiative (IAVI); Member, BioAgenda Board of Advisors 
  • Joshua Boger, PhD, Founder and CEO, Vertex Pharmaceuticals
  • G. Steven Burrill, Founder & CEO, Burrill & Company; Member, BioAgenda Board of Advisors
  • Brook Byers, Partner, Kleiner Perkins Caufield & Byers (KPCB); Member, BioAgenda Board of Advisors
  • Ronald Cape, PhD, Co-Founder, Cetus Corporation; Biotech Investor
  • Kate Carr, President and CEO, Accelerate Brain Cancer Cure (ABC2)
  • Mariana Cook, Photographer
  • David Crane, JD, Special Advisor to the California Governor for Jobs and Economic Growth
  • David Ewing Duncan, Writer; Journalist; BioAgenda Founder and Editorial Director
  • Geoffrey Duyk, MD, PhD, Managing Director, TPG Ventures; Member, BioAgenda Board of Advisors
  • Margaret Eaton, PharmD, JD, Senior Research Scholar in the Center for Biomedical Ethics at the Stanford University
  • Rodes Fishburne, Journalist, Playwright, Novelist
  • Frederick Frank, Vice Chairman, Lehman Brothers; Member, BioAgenda Board of Advisors
  • David L. Gollaher, PhD, President and CEO, California Healthcare Institute
  • Corey Goodman, PhD, President and CEO, Renovis; Professor of Neurobiology, UC Berkeley; Member, BioAgenda Board of Advisors
  • Merrill Goozner, Director, The Center for Science in the Public Interest; Author and Journalist
  • Baroness Susan Greenfield, PhD, Fullerian Professor of Physiology and Comparative Anatomy at Oxford University; Director, Royal Institution of Great Britain; Member, House of Lords; Member, BioAgenda Board of Advisors
  • Moira Gunn, PhD, Host, "Tech Nation" and "BioTech Nation", National Public Radio
  • Elin Gursky, ScD, Principal Deputy for Biodefense, National Strategies Support Directorate, ANSER Institute for Homeland Security
  • Richard Hayes, PhD, Executive Director, Center for Genetics and Society
  • David Helfand, PhD, Chairman, Astronomy Department, Columbia University
  • Susan Desmond-Hellmann, MD, President, Product Development, Genentech
  • Chris Hentschel, PhD, CEO, Medicines for Malaria Venture
  • Paul Herrling, PhD, Head of Corporate Research, Novartis; Chairman of the Board, Novartis Institute for Tropical Diseases in Singapore
  • Steven H. Holtzman, President, CEO, and Co-Founder, Infinity Pharmaceuticals; Member, BioAgenda Board of Advisors
  • William Hurlbut, MD, Consulting Professor in Neurology and Neurological Sciences, Stanford University; Member, President's Council on Bioethics
  • Dariush Kashani, Actor
  • Caroline Kovac, PhD, General Manager, IBM Healthcare and Life Sciences
  • Ray Kurzweil, PhD, Founder, Chairman, CEO, Kurzweil Technologies; best-selling author of The Age of Spiritual Machines
  • Edison Liu, MD, Executive Director, Genome Institute of Singapore; Member, BioAgenda Board of Advisors
  • The Reverend David F. McAllister-Wilson, DMin. President, Wesley Theological Seminary
  • Richard Milner, Associate in Anthropology, American Museum of Natural History; author of The Encyclopedia of Evolution: Humanity’s Search for Its Origins
  • Lord Naren Patel of Dunkeld, MD, Chairman of the United Kingdom Stem Cell Oversight Committee; Member, House of Lords; Fellow of the Royal College of Obstetricians and Gynecologists
  • Jason Pontin, Editor-in-Chief and Publisher, MIT Technology Review; Member, BioAgenda Council of Journalists 
  • Cynthia Robbins-Roth, PhD, Founder of BioVenture Publishing Inc. and BioVenture Consultants; Journalist and best-selling author of From Alchemy to IPO; Member, BioAgenda Board of Advisors
  • Joan I. Samuelson, Founder and President, Parkinson's Action Network
  • Hubert Sauper, Documentary Film Writer and Director; Author of the Oscar nominated film, Darwin's Nightmare
  • Cynthia Schneider, PhD, Distinguished Professor in the Practice of Diplomacy, Georgetown University; Former Ambassador to the Netherlands
  • Daniel Sharp, JD, President, Royal Institution World Science Assembly (RiSci); former President, The American Assembly, General Coordinator of founding conference, Club of Madrid
  • Leonard Shlain, MD, Chairman of Laparoscopic surgery at the California Pacific Medical Center in San Francisco; Associate Professor UCSF Medical School; Bestselling Author
  • Tiffany Shlain, Filmmaker; Founder/Ambassador of the Webby Awards
  • Jay P. Siegel, Group President, Research and Development Pharmaceuticals, Johnson & Johnson
  • Greg Simon, JD, President, FasterCures, part of the Milken Foundation; former Chief Domestic Policy Advisor to Vice President Al Gore
  • David A. Sinclair, PhD, Associate Professor of Pathology, Harvard Medical School
  • Kari Stefansson, MD, CEO and Co-Founder, deCODE Genetics; Member, BioAgenda Board of Advisors
  • Gregory Stock, PhD, CEO, Signum Biosciences; Director, Program on Medicine, Technology and Society, UCLA; Member, BioAgenda Board of Advisors
  • Raymond Woosley, MD, PhD, President, The Critical Path Institute; former Special Consultant to the Food and Drug Administration

 

back to top

 

Home | Vision & Programs | Events | Education & Outreach
Advisors & Team | Underwriters & Supporters | Press | Contact

Copyright © 2008 BioAgenda Institute. All Rights Reserved.
Powered by Artemis InSite System